| 引用本文：成刚,刘晓云,侯建林,等.我国基本药物零差率政策存在的问题与调整策略[J].中国卫生政策研究,2011,4(10):39-42 |
|
| 我国基本药物零差率政策存在的问题与调整策略 |
| 投稿时间：2011-09-06 修订日期：2011-09-17 PDF全文浏览 HTML全文浏览 |
| 成刚1, 刘晓云1, 侯建林1, 徐进1, 孟庆跃1 |
| 北京大学中国卫生发展研究中心 |
| 摘要:基本药物制度的根本目的是保证民众对安全有效药品的可及性。在药品政策改革实施过程中，相关利益方行为变化能否与设计目标一致，是决定政策目标能否实现及其实现程度的关键因素。基本药物零差率政策存在的主要问题包括：没有充分考虑地区发展的差异性，没有建立实现政策目标的激励机制，并且影响居民的药物可及性和“强基层”的改革目标。针对这些问题，可考虑做出如下调整：基本药物保留加成销售政策，同时允许基层卫生机构配备和使用非基本药物，但非基本药物实行零差率销售政策。 |
| 关键词:卫生体制改革 基本药物制度 零差率 |
|
| Zero mark up policy of essential medicines system in China: Problems and recommendations |
|
|
| Abstract:The aim of the national essential medicines system is to ensure the people’s accessibility to quality drugs. It is the key to the success of drug policy reform that the responses of the relevant stake holders are consistent with the designed objectives of the reform measures. The zero mark up drug policy for primary health facilities brings many problems: it is not consistent with the situation that there exists great imbalance in economic development and financing capacity between areas in China, there is no economic stimulus for primary health facilities to achieve the policy objectives, and it hurts both the accessibility of the people to non essential drugs and the objective of “strengthening the primary health facilities”. To overcome these problems, the following alternative measures are recommended: price mark up policy should be retained for essential drugs, and non essential drugs should be permitted to use in primary health facilities without price mark up. |
| Key words:Health system reform Essential medicines system Zero mark-up |
| 摘要点击次数: 7211 全文下载次数: 7780 |
|
|
